Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:PBM

Psyence Biomedical (PBM) Stock Price, News & Analysis

→ Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad)
Free PBM Stock Alerts
$0.87
-0.04 (-4.42%)
(As of 05/17/2024 08:54 PM ET)
Compare
Today's Range
$0.83
▼
$0.91
50-Day Range
$0.68
▼
$1.77
52-Week Range
$0.51
▼
$4.31
Volume
59,700 shs
Average Volume
3.01 million shs
Market Capitalization
$7.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media
PBM stock logo

About Psyence Biomedical Stock (NASDAQ:PBM)

Newcourt Acquisition Corp is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Newcourt Acquisition Corp is based in Oakland, California.

PBM Stock Price History

PBM Stock News Headlines

May 17 at 7:00 AM | globenewswire.com
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase
May 10, 2024 | americanbankingnews.com
Psyence Biomedical (NASDAQ:PBM) Trading Up 3.8%
April 17, 2024 | finance.yahoo.com
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
April 17, 2024 | globenewswire.com
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
April 16, 2024 | globenewswire.com
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
April 8, 2024 | tmcnet.com
Psyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial
April 8, 2024 | globenewswire.com
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
March 28, 2024 | finanznachrichten.de
Psyence Group Inc.: Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
March 26, 2024 | globenewswire.com
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
March 24, 2024 | morningstar.com
Psyence Biomedical Ltd PBM
March 22, 2024 | seekingalpha.com
PBM Psyence Biomedical Ltd.
March 21, 2024 | uk.investing.com
Psyence Biomedical Ltd (PBM)
March 18, 2024 | stockhouse.com
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
March 18, 2024 | globenewswire.com
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
March 17, 2024 | uk.investing.com
Psyence Biomedical faces Nasdaq delisting over market value
March 15, 2024 | globenewswire.com
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
March 12, 2024 | globenewswire.com
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
March 12, 2024 | globenewswire.com
Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones
March 11, 2024 | benzinga.com
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
March 8, 2024 | investorplace.com
Why Is Psyence Biomedical (PBM) Stock Up 90% Today?
See More Headlines

Company Calendar

Today
5/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:PBM
Previous Symbol
NASDAQ:PBM
CUSIP
N/A
CIK
1985062
Web
N/A
Phone
510-214-3750
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,790,000
Free Float
8,472,000
Market Cap
$7.65 million
Optionable
N/A
Beta
-0.11

PBM Stock Analysis - Frequently Asked Questions

How have PBM shares performed in 2024?

Psyence Biomedical's stock was trading at $2.35 at the beginning of the year. Since then, PBM shares have decreased by 63.0% and is now trading at $0.8698.
View the best growth stocks for 2024 here.

What ETF holds Psyence Biomedical's stock?

AdvisorShares Psychedelics ETF holds 325,708 shares of PBM stock, representing 4.61% of its portfolio.

How do I buy shares of Psyence Biomedical?

Shares of PBM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PBM) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders